Healthcare Sector Stocks
The Healthcare sector has a total of 1052 stocks, with a combined market cap of $8.87 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 44.25.
Market Cap
8.87T
Revenue
4.59T
Profits
200.36B
PE Ratio
44.25
Profit Margin
4.37%
Dividend Yield
0.40%
1052 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.02T | -2.73% | 2,644,156 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 598.96B | -1.67% | 8,114,644 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 447.67B | -0.44% | 4,332,812 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 382.83B | -1.07% | 4,818,694 | 450.13B |
| 5 | MRK | Merck & Co., Inc. | 307.25B | -2.43% | 7,728,228 | 65.77B |
| 6 | NVS | Novartis AG | 278.13B | -2.73% | 1,841,328 | 56.58B |
| 7 | AZN | AstraZeneca PLC | 257.69B | -2.59% | 2,552,863 | 60.44B |
| 8 | NVO | Novo Nordisk A/S | 221.55B | -1.41% | 7,298,980 | 50.57B |
| 9 | AMGN | Amgen Inc. | 196.55B | -0.58% | 1,922,110 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 195.56B | -1.17% | 1,610,989 | 45.20B |
| 11 | ABT | Abbott Laboratories | 177.07B | 0.97% | 14,390,538 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 165.39B | -0.80% | 4,103,646 | 29.74B |
| 13 | DHR | Danaher Corporation | 142.34B | -1.33% | 6,321,046 | 24.78B |
| 14 | PFE | Pfizer Inc. | 141.06B | -1.20% | 38,685,780 | 63.32B |
| 15 | CVS | CVS Health Corporation | 137.30B | 0.13% | 6,628,723 | 405.62B |
| 16 | ISRG | Intuitive Surgical, Inc. | 125.08B | 2.24% | 5,717,161 | 11.03B |
| 17 | BMY | Bristol-Myers Squibb Company | 122.85B | -0.95% | 10,186,235 | 48.48B |
| 18 | SYK | Stryker Corporation | 122.35B | -0.23% | 1,632,716 | 25.27B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 121.95B | -1.06% | 1,101,724 | 12.22B |
| 20 | MDT | Medtronic plc | 106.61B | 0.11% | 7,231,776 | 36.36B |
| 21 | SNY | Sanofi | 105.48B | -1.52% | 7,097,014 | 54.60B |
| 22 | GSK | GSK plc | 100.59B | -3.32% | 5,345,374 | 43.29B |
| 23 | MCK | McKesson Corporation | 97.35B | -1.18% | 698,171 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 82.89B | 2.44% | 1,743,578 | 201.11B |
| 25 | HCA | HCA Healthcare, Inc. | 82.17B | -0.20% | 1,498,646 | 76.39B |
| 26 | CI | The Cigna Group | 75.11B | 0.88% | 1,663,446 | 277.89B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 68.38B | -0.67% | 624,732 | 14.92B |
| 28 | BSX | Boston Scientific Corporation | 65.06B | -0.59% | 13,150,235 | 20.61B |
| 29 | COR | Cencora, Inc. | 59.14B | -1.27% | 1,230,743 | 328.68B |
| 30 | ARGX | argenx SE | 53.79B | -1.67% | 246,382 | 4.74B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 53.32B | -0.58% | 4,812,120 | 28.34B |
| 32 | CAH | Cardinal Health, Inc. | 52.87B | -1.21% | 1,711,828 | 250.74B |
| 33 | MDLN | Medline Inc. | 51.08B | -2.29% | 7,459,848 | 29.14B |
| 34 | EW | Edwards Lifesciences Corporation | 48.94B | -0.85% | 3,751,378 | 6.30B |
| 35 | HUM | Humana Inc. | 47.81B | -0.45% | 1,052,769 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 44.48B | -0.64% | 407,880 | 4.45B |
| 37 | HLN | Haleon plc | 43.86B | -0.59% | 9,764,531 | 14.85B |
| 38 | BDX | Becton, Dickinson and Company | 42.57B | -2.33% | 1,730,131 | 22.23B |
| 39 | RVMD | Revolution Medicines, Inc. | 38.35B | -3.10% | 2,538,627 | - |
| 40 | NTRA | Natera, Inc. | 37.61B | -3.23% | 833,726 | 2.50B |
| 41 | A | Agilent Technologies, Inc. | 36.79B | -0.91% | 2,470,804 | 7.23B |
| 42 | ALNY | Alnylam Pharmaceuticals, Inc. | 36.40B | 1.94% | 1,359,743 | 4.29B |
| 43 | TEVA | Teva Pharmaceutical Industries Limited | 36.10B | -3.22% | 4,515,265 | 17.35B |
| 44 | WAT | Waters Corporation | 35.11B | -3.10% | 857,485 | 3.77B |
| 45 | ONC | BeOne Medicines AG | 34.53B | -0.46% | 343,913 | 5.74B |
| 46 | ALC | Alcon Inc. | 34.17B | -0.31% | 2,446,962 | 10.63B |
| 47 | IQV | IQVIA Holdings Inc. | 34.03B | -1.14% | 836,888 | 16.63B |
| 48 | RPRX | Royalty Pharma plc | 32.99B | -1.52% | 3,245,519 | 2.44B |
| 49 | CNC | Centene Corporation | 32.51B | -0.90% | 3,420,496 | 178.33B |
| 50 | VEEV | Veeva Systems Inc. | 32.07B | 1.04% | 1,245,502 | 3.32B |
| 51 | ZTS | Zoetis Inc. | 31.95B | 0.22% | 5,635,720 | 9.53B |
| 52 | BIIB | Biogen Inc. | 29.52B | -2.93% | 963,089 | 9.94B |
| 53 | DXCM | DexCom, Inc. | 29.21B | -1.25% | 3,194,553 | 4.82B |
| 54 | RMD | ResMed Inc. | 28.65B | -0.19% | 1,037,425 | 5.54B |
| 55 | GEHC | GE HealthCare Technologies Inc. | 28.58B | -0.38% | 4,734,081 | 20.98B |
| 56 | ILMN | Illumina, Inc. | 27.94B | -1.06% | 1,497,336 | 4.39B |
| 57 | MTD | Mettler-Toledo International Inc. | 25.74B | -2.77% | 197,918 | 4.09B |
| 58 | PHG | Koninklijke Philips N.V. | 25.70B | -0.74% | 734,359 | 20.34B |
| 59 | WST | West Pharmaceutical Services, Inc. | 24.89B | -1.65% | 684,460 | 3.22B |
| 60 | ROIV | Roivant Sciences Ltd. | 24.49B | -1.33% | 6,014,318 | 8.26M |
| 61 | MRNA | Moderna, Inc. | 23.60B | -3.77% | 4,967,921 | 2.23B |
| 62 | BNTX | BioNTech SE | 23.31B | 0.74% | 687,714 | 3.23B |
| 63 | INSM | Insmed Incorporated | 23.20B | -1.20% | 2,015,830 | 819.56M |
| 64 | INCY | Incyte Corporation | 23.10B | -1.36% | 1,257,075 | 5.36B |
| 65 | LH | Labcorp Holdings Inc. | 23.08B | -0.66% | 777,603 | 14.14B |
| 66 | DGX | Quest Diagnostics Incorporated | 22.99B | -1.43% | 822,908 | 11.28B |
| 67 | UTHR | United Therapeutics Corporation | 22.47B | -1.18% | 318,876 | 3.17B |
| 68 | STE | STERIS plc | 20.90B | -1.55% | 743,567 | 5.94B |
| 69 | VTRS | Viatris Inc. | 19.79B | -1.74% | 7,852,888 | 14.56B |
| 70 | GH | Guardant Health, Inc. | 19.63B | -5.00% | 2,522,360 | 1.08B |
| 71 | NBIX | Neurocrine Biosciences, Inc. | 17.40B | 1.24% | 977,544 | 3.10B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 17.36B | -1.54% | 2,150,821 | 8.41B |
| 73 | GMAB | Genmab A/S | 17.31B | -2.82% | 1,245,539 | 3.90B |
| 74 | THC | Tenet Healthcare Corporation | 16.74B | -0.27% | 802,422 | 21.46B |
| 75 | BBIO | BridgeBio Pharma, Inc. | 15.83B | -0.76% | 1,746,480 | 579.96M |
| 76 | ASND | Ascendis Pharma A/S | 15.64B | -3.54% | 515,426 | 998.25M |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 15.29B | -1.64% | 675,769 | 4.44B |
| 78 | MEDP | Medpace Holdings, Inc. | 15.08B | -1.82% | 283,506 | 2.68B |
| 79 | DVA | DaVita Inc. | 15.03B | -1.21% | 505,192 | 13.84B |
| 80 | BTSG | BrightSpring Health Services, Inc. | 14.69B | -0.27% | 2,727,460 | 13.65B |
| 81 | COO | The Cooper Companies, Inc. | 13.96B | -0.17% | 2,354,618 | 4.23B |
| 82 | EXEL | Exelixis, Inc. | 13.96B | -0.70% | 2,381,658 | 2.38B |
| 83 | SOLV | Solventum Corporation | 13.72B | -2.53% | 965,885 | 8.26B |
| 84 | SNN | Smith & Nephew plc | 12.85B | -0.52% | 2,315,912 | 6.16B |
| 85 | FMS | Fresenius Medical Care AG | 12.81B | -0.17% | 509,060 | 22.32B |
| 86 | ICLR | ICON Public Limited Company | 12.73B | -2.25% | 703,014 | 8.27B |
| 87 | ELAN | Elanco Animal Health Incorporated | 12.56B | -2.67% | 3,665,936 | 4.89B |
| 88 | ALGN | Align Technology, Inc. | 12.54B | -0.97% | 1,060,179 | 4.10B |
| 89 | PEN | Penumbra, Inc. | 12.51B | -0.10% | 442,346 | 1.45B |
| 90 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.35B | -3.21% | 223,794 | 1.13B |
| 91 | MOH | Molina Healthcare, Inc. | 11.97B | 1.93% | 832,972 | 43.10B |
| 92 | RVTY | Revvity, Inc. | 11.87B | -3.37% | 1,248,505 | 2.90B |
| 93 | ABVX | ABIVAX Société Anonyme | 11.61B | -3.77% | 1,092,375 | 5.67M |
| 94 | PODD | Insulet Corporation | 11.59B | 2.02% | 1,652,989 | 2.90B |
| 95 | BMRN | BioMarin Pharmaceutical Inc. | 11.43B | -0.81% | 1,177,854 | 3.24B |
| 96 | AXSM | Axsome Therapeutics, Inc. | 11.41B | -3.63% | 776,274 | 708.24M |
| 97 | BAX | Baxter International Inc. | 11.40B | -2.39% | 4,980,248 | 11.32B |
| 98 | TECH | Bio-Techne Corporation | 11.16B | -0.67% | 3,217,113 | 1.21B |
| 99 | EHC | Encompass Health Corporation | 11.16B | 0.26% | 796,483 | 6.07B |
| 100 | CYTK | Cytokinetics, Incorporated | 10.74B | -1.33% | 1,468,719 | 105.82M |
| 101 | CRL | Charles River Laboratories International, Inc. | 10.58B | -2.07% | 953,019 | 4.03B |
| 102 | RDY | Dr. Reddy's Laboratories Limited | 10.56B | -0.56% | 2,038,298 | 3.58B |
| 103 | SMMT | Summit Therapeutics Inc. | 10.48B | -2.24% | 2,706,454 | - |
| 104 | GMED | Globus Medical, Inc. | 10.32B | -1.29% | 1,622,617 | 3.10B |
| 105 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.09B | -3.57% | 2,410,632 | 622.01M |
| 106 | APGE | Apogee Therapeutics, Inc. | 10.05B | 0.11% | 917,434 | - |
| 107 | KRYS | Krystal Biotech, Inc. | 10.00B | -4.41% | 337,898 | 417.30M |
| 108 | ENSG | The Ensign Group, Inc. | 9.97B | 0.44% | 354,074 | 5.27B |
| 109 | CORT | Corcept Therapeutics Incorporated | 9.83B | 1.16% | 1,611,902 | 769.10M |
| 110 | HSIC | Henry Schein, Inc. | 9.82B | -1.84% | 1,427,810 | 13.38B |
| 111 | HALO | Halozyme Therapeutics, Inc. | 9.14B | -0.93% | 1,552,632 | 1.51B |
| 112 | KYMR | Kymera Therapeutics, Inc. | 9.14B | -4.07% | 544,345 | 51.48M |
| 113 | GKOS | Glaukos Corporation | 9.13B | -0.87% | 402,913 | 551.35M |
| 114 | UHS | Universal Health Services, Inc. | 9.12B | -0.34% | 687,302 | 17.76B |
| 115 | OSCR | Oscar Health, Inc. | 8.91B | 1.72% | 3,190,865 | 13.30B |
| 116 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.84B | 0.01% | 3,602,073 | 18.07M |
| 117 | IONS | Ionis Pharmaceuticals, Inc. | 8.75B | -2.65% | 2,194,824 | 1.06B |
| 118 | TEM | Tempus AI, Inc. | 8.69B | -7.74% | 10,289,578 | 1.36B |
| 119 | PTGX | Protagonist Therapeutics, Inc. | 8.64B | -4.71% | 762,727 | 74.06M |
| 120 | ALKS | Alkermes plc | 8.62B | -1.90% | 941,817 | 1.56B |
| 121 | SYRE | Spyre Therapeutics, Inc. | 8.56B | -2.89% | 750,058 | - |
| 122 | BRKR | Bruker Corporation | 8.55B | -3.54% | 1,769,154 | 3.46B |
| 123 | PRAX | Praxis Precision Medicines, Inc. | 8.49B | -3.17% | 233,266 | 7.46M |
| 124 | QGEN | Qiagen N.V. | 8.37B | -1.63% | 1,937,808 | 2.10B |
| 125 | ATR | AptarGroup, Inc. | 8.29B | -2.04% | 422,949 | 3.87B |
| 126 | HQY | HealthEquity, Inc. | 8.27B | 1.24% | 485,428 | 1.34B |
| 127 | RGEN | Repligen Corporation | 8.21B | -1.20% | 887,483 | 763.34M |
| 128 | IMVT | Immunovant, Inc. | 8.20B | -0.84% | 733,370 | - |
| 129 | BIO | Bio-Rad Laboratories, Inc. | 8.08B | -0.81% | 454,218 | 2.59B |
| 130 | PCVX | Vaxcyte, Inc. | 8.01B | -1.25% | 870,516 | - |
| 131 | IBRX | ImmunityBio, Inc. | 7.85B | -2.41% | 7,238,607 | 140.98M |
| 132 | TGTX | TG Therapeutics, Inc. | 7.65B | -1.66% | 1,029,099 | 700.35M |
| 133 | HIMS | Hims & Hers Health, Inc. | 7.57B | -0.43% | 8,342,740 | 2.37B |
| 134 | AVTR | Avantor, Inc. | 7.28B | -3.70% | 9,383,288 | 6.55B |
| 135 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.17B | -1.88% | 466,551 | 217.17M |
| 136 | MIRM | Mirum Pharmaceuticals, Inc. | 7.11B | -1.88% | 365,741 | 569.61M |
| 137 | PACS | PACS Group, Inc. | 7.08B | -3.03% | 758,802 | 5.43B |
| 138 | LQDA | Liquidia Corporation | 6.85B | -3.58% | 1,012,646 | 288.07M |
| 139 | LNTH | Lantheus Holdings, Inc. | 6.80B | -2.96% | 710,119 | 1.55B |
| 140 | CHE | Chemed Corporation | 6.79B | 0.72% | 138,307 | 2.54B |
| 141 | HNGE | Hinge Health, Inc. | 6.79B | 0.70% | 1,150,889 | 646.34M |
| 142 | COGT | Cogent Biosciences, Inc. | 6.55B | -2.00% | 1,170,322 | - |
| 143 | ERAS | Erasca, Inc. | 6.53B | -1.83% | 3,395,368 | - |
| 144 | GRFS | Grifols, S.A. | 6.50B | 4.68% | 639,541 | 8.58B |
| 145 | PTCT | PTC Therapeutics, Inc. | 6.47B | -0.74% | 954,313 | 827.11M |
| 146 | XENE | Xenon Pharmaceuticals Inc. | 6.38B | -3.25% | 701,589 | 7.50M |
| 147 | CGON | CG Oncology, Inc. | 6.19B | -2.31% | 1,045,638 | 5.07M |
| 148 | SRRK | Scholar Rock Holding Corporation | 6.07B | -4.16% | 898,224 | - |
| 149 | BLTE | Belite Bio, Inc | 6.01B | 1.84% | 235,467 | - |
| 150 | TFX | Teleflex Incorporated | 5.93B | -0.43% | 294,668 | 2.13B |
| 151 | LGND | Ligand Pharmaceuticals Incorporated | 5.82B | -3.10% | 395,557 | 274.48M |
| 152 | BLLN | BillionToOne, Inc. | 5.76B | -3.97% | 659,902 | 354.54M |
| 153 | BLCO | Bausch + Lomb Corporation | 5.70B | -1.72% | 349,785 | 5.21B |
| 154 | DFTX | Definium Therapeutics, Inc. | 5.68B | -3.36% | 1,221,980 | - |
| 155 | AMRX | Amneal Pharmaceuticals, Inc. | 5.58B | -1.96% | 1,222,879 | 3.05B |
| 156 | ORKA | Oruka Therapeutics, Inc. | 5.53B | -1.07% | 1,339,367 | - |
| 157 | DNTH | Dianthus Therapeutics, Inc. | 5.52B | -4.36% | 837,638 | 1.34M |
| 158 | TXG | 10x Genomics, Inc. | 5.49B | -1.19% | 2,383,838 | 638.78M |
| 159 | TWST | Twist Bioscience Corporation | 5.45B | -6.82% | 931,086 | 409.48M |
| 160 | STVN | Stevanato Group S.p.A. | 5.23B | -0.10% | 307,043 | 1.39B |
| 161 | TVTX | Travere Therapeutics, Inc. | 5.16B | -2.19% | 765,572 | 536.20M |
| 162 | SHC | Sotera Health Company | 4.97B | -1.86% | 2,197,922 | 1.19B |
| 163 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.81B | -2.14% | 520,535 | 754.05M |
| 164 | RDNT | RadNet, Inc. | 4.77B | -2.43% | 591,367 | 2.14B |
| 165 | INDV | Indivior Pharmaceuticals, Inc. | 4.77B | -3.50% | 2,538,337 | 1.29B |
| 166 | MMED | MiniMed Group, Inc. | 4.75B | -0.06% | 1,158,032 | 3.10B |
| 167 | CRSP | CRISPR Therapeutics AG | 4.63B | -1.65% | 1,647,194 | 4.10M |
| 168 | VCYT | Veracyte, Inc. | 4.57B | -3.16% | 1,847,987 | 541.74M |
| 169 | LEGN | Legend Biotech Corporation | 4.49B | 4.27% | 2,790,564 | 1.14B |
| 170 | MMSI | Merit Medical Systems, Inc. | 4.48B | 1.59% | 737,770 | 1.54B |
| 171 | MANE | Veradermics, Incorporated | 4.43B | -4.74% | 568,032 | - |
| 172 | CAI | Caris Life Sciences, Inc. | 4.40B | -5.64% | 2,766,256 | 907.29M |
| 173 | LFST | LifeStance Health Group, Inc. | 4.40B | -2.07% | 2,248,545 | 1.49B |
| 174 | ALHC | Alignment Healthcare, Inc. | 4.36B | 2.43% | 4,226,438 | 4.26B |
| 175 | LIVN | LivaNova PLC | 4.35B | -1.85% | 602,023 | 1.43B |
| 176 | NVST | Envista Holdings Corporation | 4.33B | -0.60% | 1,722,708 | 2.81B |
| 177 | ACAD | ACADIA Pharmaceuticals Inc. | 4.30B | -1.99% | 1,486,526 | 1.10B |
| 178 | CELC | Celcuity Inc. | 4.29B | -0.44% | 1,053,653 | - |
| 179 | WAY | Waystar Holding Corp. | 4.24B | -0.81% | 2,946,362 | 1.16B |
| 180 | VKTX | Viking Therapeutics, Inc. | 4.22B | -1.89% | 1,911,409 | - |
| 181 | RLAY | Relay Therapeutics, Inc. | 4.18B | -3.67% | 3,492,075 | 10.68M |
| 182 | EWTX | Edgewise Therapeutics, Inc. | 4.18B | -2.39% | 618,630 | - |
| 183 | CON | Concentra Group Holdings Parent, Inc. | 4.01B | -0.95% | 796,277 | 2.23B |
| 184 | TNGX | Tango Therapeutics, Inc. | 3.98B | -3.57% | 1,256,947 | 56.99M |
| 185 | ICUI | ICU Medical, Inc. | 3.93B | -0.11% | 289,429 | 2.16B |
| 186 | DOCS | Doximity, Inc. | 3.91B | 0.98% | 3,637,649 | 644.86M |
| 187 | DYN | Dyne Therapeutics, Inc. | 3.88B | -1.22% | 2,528,742 | - |
| 188 | IRTC | iRhythm Holdings, Inc. | 3.66B | 0.44% | 316,648 | 787.85M |
| 189 | DNLI | Denali Therapeutics Inc. | 3.63B | -1.67% | 1,224,005 | - |
| 190 | ELVN | Enliven Therapeutics, Inc. | 3.61B | -2.88% | 581,020 | - |
| 191 | TLX | Telix Pharmaceuticals Limited | 3.59B | 0.48% | 137,405 | 803.79M |
| 192 | ALMS | Alumis Inc. | 3.57B | -2.37% | 694,494 | 8.40M |
| 193 | BKD | Brookdale Senior Living Inc. | 3.56B | -0.53% | 4,049,585 | 3.00B |
| 194 | HAE | Haemonetics Corporation | 3.55B | 0.40% | 577,721 | 1.33B |
| 195 | RCUS | Arcus Biosciences, Inc. | 3.54B | 2.92% | 1,127,432 | 236.00M |
| 196 | OGN | Organon & Co. | 3.54B | -0.22% | 1,963,791 | 6.16B |
| 197 | ADPT | Adaptive Biotechnologies Corporation | 3.50B | -4.62% | 2,140,014 | 295.41M |
| 198 | PBLS | Parabilis Medicines, Inc. | 3.48B | -7.58% | 641,872 | - |
| 199 | NAMS | NewAmsterdam Pharma Company N.V. | 3.47B | -6.34% | 1,638,529 | 22.57M |
| 200 | ARQT | Arcutis Biotherapeutics, Inc. | 3.44B | -3.37% | 1,254,116 | 415.62M |
| 201 | NHC | National HealthCare Corporation | 3.43B | -3.63% | 78,520 | 1.53B |
| 202 | OPCH | Option Care Health, Inc. | 3.42B | 0.05% | 1,722,139 | 5.67B |
| 203 | IDYA | IDEAYA Biosciences, Inc. | 3.37B | -1.56% | 645,037 | 225.27M |
| 204 | GPCR | Structure Therapeutics Inc. | 3.34B | -3.09% | 406,730 | - |
| 205 | PRVA | Privia Health Group, Inc. | 3.31B | -2.38% | 987,906 | 2.25B |
| 206 | ITGR | Integer Holdings Corporation | 3.26B | 0.70% | 280,016 | 1.86B |
| 207 | ACHC | Acadia Healthcare Company, Inc. | 3.17B | -0.20% | 1,615,245 | 3.37B |
| 208 | WRBY | Warby Parker Inc. | 3.02B | -6.89% | 4,014,255 | 890.57M |
| 209 | GRAL | GRAIL, Inc. | 2.96B | -5.11% | 449,970 | 156.12M |
| 210 | MBX | MBX Biosciences, Inc. | 2.86B | -4.42% | 646,702 | - |
| 211 | IRON | Disc Medicine, Inc. | 2.84B | -2.32% | 310,454 | - |
| 212 | RARE | Ultragenyx Pharmaceutical Inc. | 2.80B | -2.56% | 1,255,066 | 670.00M |
| 213 | CLDX | Celldex Therapeutics, Inc. | 2.78B | 0.20% | 527,637 | 865.00K |
| 214 | SUPN | Supernus Pharmaceuticals, Inc. | 2.75B | -1.29% | 618,820 | 776.83M |
| 215 | ESTA | Establishment Labs Holdings Inc. | 2.75B | 0.91% | 732,967 | 229.58M |
| 216 | QURE | uniQure N.V. | 2.73B | -1.37% | 1,070,204 | 18.09M |
| 217 | XRAY | DENTSPLY SIRONA Inc. | 2.70B | -4.20% | 4,867,954 | 3.68B |
| 218 | ATAI | AtaiBeckley Inc. | 2.66B | -0.42% | 22,302,230 | 3.49M |
| 219 | VERA | Vera Therapeutics, Inc. | 2.66B | -3.92% | 1,014,704 | - |
| 220 | BEAM | Beam Therapeutics Inc. | 2.62B | -4.36% | 2,767,729 | 164.01M |
| 221 | KOD | Kodiak Sciences Inc. | 2.55B | -4.15% | 500,556 | - |
| 222 | TMDX | TransMedics Group, Inc. | 2.54B | -0.69% | 1,117,548 | 635.89M |
| 223 | RGC | Regencell Bioscience Holdings Limited | 2.53B | 1.59% | 148,596 | - |
| 224 | GRDN | Guardian Pharmacy Services, Inc. | 2.52B | -1.83% | 232,282 | 1.46B |
| 225 | IMNM | Immunome, Inc. | 2.51B | -0.72% | 673,240 | 4.02M |
| 226 | PGNY | Progyny, Inc. | 2.49B | -0.50% | 687,790 | 1.29B |
| 227 | SLS | SELLAS Life Sciences Group, Inc. | 2.45B | -5.42% | 7,289,646 | - |
| 228 | TARS | Tarsus Pharmaceuticals, Inc. | 2.42B | -6.02% | 1,520,767 | 535.08M |
| 229 | PBH | Prestige Consumer Healthcare Inc. | 2.39B | 0.98% | 772,738 | 1.09B |
| 230 | AGIO | Agios Pharmaceuticals, Inc. | 2.38B | 1.14% | 635,501 | 66.05M |
| 231 | TRVI | Trevi Therapeutics, Inc. | 2.38B | -12.06% | 3,055,803 | - |
| 232 | CLOV | Clover Health Investments, Corp. | 2.37B | -2.60% | 3,784,122 | 2.21B |
| 233 | NRIX | Nurix Therapeutics, Inc. | 2.36B | -1.77% | 1,393,414 | 36.77M |
| 234 | MLYS | Mineralys Therapeutics, Inc. | 2.35B | -1.40% | 501,004 | - |
| 235 | PHVS | Pharvaris N.V. | 2.34B | -3.98% | 249,259 | - |
| 236 | VCEL | Vericel Corporation | 2.34B | -1.63% | 637,094 | 292.09M |
| 237 | LMAT | LeMaitre Vascular, Inc. | 2.32B | 0.06% | 167,833 | 256.28M |
| 238 | KLRA | Kailera Therapeutics, Inc. | 2.32B | -3.45% | 381,479 | - |
| 239 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.32B | -1.94% | 2,383,762 | 885.72M |
| 240 | COAG | Hemab Therapeutics Holdings, Inc. | 2.31B | 0.20% | 568,920 | - |
| 241 | ZLAB | Zai Lab Limited | 2.31B | 1.58% | 385,833 | 453.28M |
| 242 | IOVA | Iovance Biotherapeutics, Inc. | 2.24B | 0.40% | 16,361,516 | 285.61M |
| 243 | BHVN | Biohaven Ltd. | 2.24B | -3.76% | 1,784,453 | - |
| 244 | MESO | Mesoblast Limited | 2.21B | -3.98% | 348,831 | 65.38M |
| 245 | NKTR | Nektar Therapeutics | 2.19B | -5.01% | 748,031 | 55.63M |
| 246 | NUVB | Nuvation Bio Inc. | 2.18B | 7.93% | 11,998,916 | 143.05M |
| 247 | NEOG | Neogen Corporation | 2.18B | -2.53% | 1,029,536 | 870.56M |
| 248 | HTFL | HeartFlow, Inc. | 2.12B | -1.29% | 1,105,700 | 191.42M |
| 249 | AVAH | Aveanna Healthcare Holdings Inc. | 2.11B | - | 2,152,975 | 2.52B |
| 250 | AXGN | Axogen, Inc. | 2.10B | -0.93% | 1,063,951 | 238.11M |
| 251 | SGRY | Surgery Partners, Inc. | 2.08B | 0.25% | 904,190 | 3.34B |
| 252 | SION | Sionna Therapeutics, Inc. | 2.06B | -7.53% | 816,701 | - |
| 253 | MD | Pediatrix Medical Group, Inc. | 2.06B | -1.61% | 502,748 | 1.93B |
| 254 | OMCL | Omnicell, Inc. | 2.06B | -1.42% | 554,095 | 1.23B |
| 255 | VRDN | Viridian Therapeutics, Inc. | 2.05B | 2.94% | 2,180,554 | 70.92M |
| 256 | ADUS | Addus HomeCare Corporation | 2.04B | -2.64% | 299,737 | 1.45B |
| 257 | AGL | agilon health, inc. | 2.04B | -5.96% | 387,022 | 5.82B |
| 258 | DMRA | Damora Therapeutics, Inc. | 2.03B | 4.80% | 350,606 | - |
| 259 | ADMA | ADMA Biologics, Inc. | 2.03B | 0.46% | 2,486,901 | 509.86M |
| 260 | ASTH | Astrana Health, Inc. | 2.01B | -0.87% | 578,785 | 3.53B |
| 261 | PLSE | Pulse Biosciences, Inc. | 2.00B | 0.98% | 267,370 | 751.00K |
| 262 | URGN | UroGen Pharma Ltd. | 2.00B | 2.21% | 550,393 | 140.49M |
| 263 | HCM | HUTCHMED (China) Limited | 2.00B | 4.43% | 78,784 | 548.51M |
| 264 | GLUE | Monte Rosa Therapeutics, Inc. | 1.98B | -4.40% | 884,555 | 42.95M |
| 265 | CDNA | CareDx, Inc. | 1.98B | -3.42% | 1,183,770 | 412.82M |
| 266 | SNDX | Syndax Pharmaceuticals, Inc. | 1.98B | -2.24% | 1,308,636 | 217.17M |
| 267 | AUPH | Aurinia Pharmaceuticals Inc. | 1.96B | -4.45% | 999,961 | 298.30M |
| 268 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.94B | -1.69% | 1,681,398 | -665.00K |
| 269 | HRMY | Harmony Biosciences Holdings, Inc. | 1.94B | -0.80% | 1,074,405 | 899.11M |
| 270 | ZBIO | Zenas BioPharma, Inc. | 1.94B | 3.96% | 885,303 | 10.00M |
| 271 | LKFT | Lakefront Biotherapeutics NV | 1.93B | -3.30% | 156,718 | 1.20B |
| 272 | RAPP | Rapport Therapeutics, Inc. | 1.92B | -5.65% | 365,745 | 20.00M |
| 273 | KARD | Kardigan, Inc. | 1.91B | 1.28% | 331,055 | - |
| 274 | OCUL | Ocular Therapeutix, Inc. | 1.91B | -2.90% | 2,496,858 | 52.04M |
| 275 | UFPT | UFP Technologies, Inc. | 1.90B | 1.47% | 157,659 | 608.85M |
| 276 | SNDA | Sonida Senior Living, Inc. | 1.89B | -0.71% | 263,747 | 367.34M |
| 277 | GHRS | GH Research PLC | 1.89B | -4.11% | 205,877 | - |
| 278 | NEO | NeoGenomics, Inc. | 1.85B | -2.53% | 2,092,722 | 745.97M |
| 279 | TYRA | Tyra Biosciences, Inc. | 1.85B | -3.35% | 348,453 | - |
| 280 | NVCR | NovoCure Limited | 1.85B | 0.13% | 933,512 | 674.41M |
| 281 | NBTX | Nanobiotix S.A. | 1.81B | -5.45% | 181,559 | 38.27M |
| 282 | PGEN | Precigen, Inc. | 1.81B | 2.42% | 3,483,736 | 31.60M |
| 283 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.80B | -3.45% | 2,302,911 | 204.73M |
| 284 | WGS | GeneDx Holdings Corp. | 1.80B | -4.46% | 484,590 | 442.68M |
| 285 | TSHA | Taysha Gene Therapies, Inc. | 1.78B | -6.38% | 1,675,121 | 7.47M |
| 286 | BCAX | Bicara Therapeutics Inc. | 1.78B | -2.20% | 287,311 | - |
| 287 | PVLA | Palvella Therapeutics, Inc. | 1.78B | -21.04% | 557,962 | - |
| 288 | SRPT | Sarepta Therapeutics, Inc. | 1.78B | -2.26% | 1,777,090 | 2.18B |
| 289 | ABCL | AbCellera Biologics Inc. | 1.77B | -10.29% | 6,370,689 | 79.21M |
| 290 | ATRC | AtriCure, Inc. | 1.76B | -0.52% | 1,070,115 | 552.16M |
| 291 | BFLY | Butterfly Network, Inc. | 1.75B | 1.06% | 9,226,132 | 102.92M |
| 292 | BHC | Bausch Health Companies Inc. | 1.75B | -3.11% | 2,074,660 | 10.53B |
| 293 | TDOC | Teladoc Health, Inc. | 1.74B | 2.33% | 3,572,475 | 2.51B |
| 294 | GENB | Generate Biomedicines, Inc. | 1.74B | 0.15% | 421,926 | 30.30M |
| 295 | IMCR | Immunocore Holdings plc | 1.73B | -2.60% | 438,533 | 412.81M |
| 296 | STOK | Stoke Therapeutics, Inc. | 1.72B | -4.72% | 698,519 | 32.08M |
| 297 | HCSG | Healthcare Services Group, Inc. | 1.71B | -1.42% | 768,309 | 1.85B |
| 298 | AAPG | Ascentage Pharma Group International | 1.71B | -1.97% | 1,186 | 82.08M |
| 299 | ZYME | Zymeworks Inc. | 1.70B | -1.78% | 437,382 | 81.26M |
| 300 | TRLV | Trulieve Cannabis Corp. | 1.68B | -0.34% | 570,153 | 1.17B |
| 301 | FTRE | Fortrea Holdings Inc. | 1.68B | -0.17% | 680,651 | 2.71B |
| 302 | ALMR | Alamar Biosciences, Inc. | 1.66B | -7.82% | 205,937 | 87.16M |
| 303 | HROW | Harrow, Inc. | 1.66B | -4.72% | 836,675 | 268.68M |
| 304 | ANIP | ANI Pharmaceuticals, Inc. | 1.65B | -1.87% | 445,611 | 923.71M |
| 305 | MPLT | MapLight Therapeutics, Inc. | 1.63B | -4.96% | 599,287 | - |
| 306 | CMPS | COMPASS Pathways plc | 1.57B | -5.51% | 5,578,982 | - |
| 307 | MLTX | MoonLake Immunotherapeutics | 1.57B | -3.20% | 628,195 | - |
| 308 | INVA | Innoviva, Inc. | 1.57B | -1.98% | 705,615 | 420.69M |
| 309 | MAZE | Maze Therapeutics, Inc. | 1.57B | 0.89% | 406,443 | 20.00M |
| 310 | XERS | Xeris Biopharma Holdings, Inc. | 1.56B | -2.27% | 1,304,709 | 314.85M |
| 311 | VIR | Vir Biotechnology, Inc. | 1.56B | -2.12% | 1,475,082 | 65.50M |
| 312 | ENOV | Enovis Corporation | 1.54B | -0.85% | 876,810 | 2.28B |
| 313 | INSP | Inspire Medical Systems, Inc. | 1.53B | 5.28% | 784,124 | 915.25M |
| 314 | RXRX | Recursion Pharmaceuticals, Inc. | 1.53B | -1.87% | 20,807,965 | 66.41M |
| 315 | NTLA | Intellia Therapeutics, Inc. | 1.53B | -4.04% | 3,740,865 | 66.09M |
| 316 | INNV | InnovAge Holding Corp. | 1.50B | -3.65% | 334,239 | 949.17M |
| 317 | ARDT | Ardent Health, Inc. | 1.50B | 2.86% | 583,896 | 6.43B |
| 318 | ANAB | AnaptysBio, Inc. | 1.49B | -13.29% | 1,248,433 | 232.39M |
| 319 | IART | Integra LifeSciences Holdings Corporation | 1.47B | -1.87% | 715,054 | 1.64B |
| 320 | PRGO | Perrigo Company plc | 1.47B | -1.21% | 2,333,252 | 4.18B |
| 321 | AHCO | AdaptHealth Corp. | 1.46B | 0.18% | 1,336,507 | 3.29B |
| 322 | SEPN | Septerna, Inc. | 1.45B | -3.56% | 197,219 | 72.26M |
| 323 | PNTG | The Pennant Group, Inc. | 1.43B | -1.91% | 189,478 | 1.02B |
| 324 | BLFS | BioLife Solutions, Inc. | 1.42B | -0.21% | 650,062 | 101.66M |
| 325 | OMDA | Omada Health, Inc. | 1.42B | 0.80% | 885,739 | 283.30M |
| 326 | PSNL | Personalis, Inc. | 1.40B | -13.32% | 12,072,446 | 64.52M |
| 327 | XNCR | Xencor, Inc. | 1.39B | 7.67% | 2,862,259 | 97.36M |
| 328 | SVRA | Savara Inc. | 1.39B | -0.54% | 1,364,992 | - |
| 329 | ABSI | Absci Corporation | 1.38B | -1.69% | 3,073,061 | 1.84M |
| 330 | KMTS | Kestra Medical Technologies, Ltd. | 1.36B | -4.83% | 428,045 | 95.13M |
| 331 | AHG | Akso Health Group | 1.35B | 4.64% | 12,293 | 14.84M |
| 332 | PAHC | Phibro Animal Health Corporation | 1.34B | -0.78% | 214,566 | 1.50B |
| 333 | AKTS | Aktis Oncology, Inc. | 1.32B | -3.74% | 262,028 | 8.28M |
| 334 | AVBP | ArriVent BioPharma, Inc. | 1.31B | -14.97% | 924,501 | - |
| 335 | AMN | AMN Healthcare Services, Inc. | 1.31B | -3.54% | 669,753 | 3.42B |
| 336 | CNMD | CONMED Corporation | 1.31B | 0.58% | 630,908 | 1.37B |
| 337 | NVAX | Novavax, Inc. | 1.30B | -4.02% | 3,029,402 | 596.34M |
| 338 | TRAX | First Tracks Biotherapeutics, Inc. | 1.29B | 0.96% | 748,435 | - |
| 339 | ATEC | Alphatec Holdings, Inc. | 1.27B | -3.16% | 2,089,097 | 787.08M |
| 340 | AVLN | Avalyn Pharma Inc. | 1.27B | 1.17% | 195,720 | - |
| 341 | IMTX | Immatics N.V. | 1.26B | -3.75% | 173,314 | 43.00M |
| 342 | ARDX | Ardelyx, Inc. | 1.26B | -2.12% | 2,367,404 | 427.68M |
| 343 | TNDM | Tandem Diabetes Care, Inc. | 1.24B | 5.97% | 1,976,357 | 1.03B |
| 344 | IRMD | IRADIMED CORPORATION | 1.24B | - | 75,919 | 86.28M |
| 345 | INBX | Inhibrx Biosciences, Inc. | 1.23B | -3.78% | 352,526 | 1.30M |
| 346 | AORT | Artivion, Inc. | 1.23B | 1.24% | 460,287 | 458.69M |
| 347 | MNKD | MannKind Corporation | 1.23B | -1.24% | 3,024,793 | 360.78M |
| 348 | ALVO | Alvotech | 1.22B | -1.45% | 540,101 | 562.04M |
| 349 | DRTS | Alpha Tau Medical Ltd. | 1.21B | -0.59% | 620,213 | - |
| 350 | AZTA | Azenta, Inc. | 1.21B | -0.11% | 346,152 | 596.48M |
| 351 | STAA | STAAR Surgical Company | 1.19B | -9.34% | 2,896,458 | 290.38M |
| 352 | CRVS | Corvus Pharmaceuticals, Inc. | 1.19B | -5.37% | 656,655 | - |
| 353 | AVNS | Avanos Medical, Inc. | 1.17B | 0.08% | 314,465 | 715.90M |
| 354 | JBIO | Jade Biosciences, Inc. | 1.17B | -5.70% | 626,408 | - |
| 355 | FBRX | Forte Biosciences, Inc. | 1.16B | -2.80% | 602,088 | - |
| 356 | COLL | Collegium Pharmaceutical, Inc. | 1.15B | -1.50% | 383,540 | 796.33M |
| 357 | USPH | U.S. Physical Therapy, Inc. | 1.13B | 1.17% | 228,313 | 787.69M |
| 358 | MGTX | MeiraGTx Holdings plc | 1.13B | -1.85% | 482,070 | 79.76M |
| 359 | QDEL | QuidelOrtho Corporation | 1.13B | -4.60% | 728,917 | 2.66B |
| 360 | CAPR | Capricor Therapeutics, Inc. | 1.13B | 0.31% | 1,911,478 | 11.13M |
| 361 | ETON | Eton Pharmaceuticals, Inc. | 1.13B | -2.95% | 739,686 | 86.93M |
| 362 | SDGR | Schrödinger, Inc. | 1.12B | -2.09% | 941,772 | 254.91M |
| 363 | NUTX | Nutex Health Inc. | 1.11B | -0.93% | 77,454 | 879.95M |
| 364 | WVE | Wave Life Sciences Ltd. | 1.10B | -1.55% | 1,333,649 | 71.80M |
| 365 | SPTX | Seaport Therapeutics, Inc. | 1.10B | -1.44% | 63,406 | - |
| 366 | PRCT | PROCEPT BioRobotics Corporation | 1.09B | - | 1,151,206 | 322.02M |
| 367 | CERT | Certara, Inc. | 1.08B | 0.14% | 1,942,178 | 419.75M |
| 368 | ORIC | ORIC Pharmaceuticals, Inc. | 1.08B | -2.89% | 821,940 | - |
| 369 | CGEM | Cullinan Therapeutics, Inc. | 1.08B | -1.07% | 472,288 | - |
| 370 | LMRI | Lumexa Imaging Holdings, Inc. | 1.07B | -0.36% | 710,642 | 1.03B |
| 371 | GDRX | GoodRx Holdings, Inc. | 1.06B | - | 1,655,164 | 787.89M |
| 372 | EYPT | EyePoint, Inc. | 1.06B | -4.81% | 1,099,630 | 7.61M |
| 373 | CRON | Cronos Group Inc. | 1.05B | 0.36% | 584,579 | 159.54M |
| 374 | IVA | Inventiva S.A. | 1.04B | -4.44% | 774,108 | 7.94M |
| 375 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | -2.51% | 3,095,644 | 69.64M |
| 376 | GMRS | GMR Solutions Inc. | 1.01B | -2.85% | 276,085 | 5.83B |
| 377 | ANRO | Alto Neuroscience, Inc. | 1.01B | -5.95% | 617,905 | - |
| 378 | PCRX | Pacira BioSciences, Inc. | 997.47M | -1.02% | 501,287 | 734.86M |
| 379 | BIOA | BioAge Labs, Inc. | 992.19M | -2.15% | 325,492 | 10.32M |
| 380 | OLMA | Olema Pharmaceuticals, Inc. | 991.39M | -1.05% | 747,620 | - |
| 381 | JANX | Janux Therapeutics, Inc. | 978.80M | -1.29% | 805,001 | 13.73M |
| 382 | BVS | Bioventus Inc. | 967.33M | -3.98% | 824,995 | 576.30M |
| 383 | AVTX | Avalo Therapeutics, Inc. | 963.36M | -5.99% | 708,024 | 59.00K |
| 384 | KURA | Kura Oncology, Inc. | 948.11M | -1.66% | 821,127 | 71.64M |
| 385 | VOR | Vor Biopharma Inc. | 945.54M | -3.54% | 663,543 | - |
| 386 | SANA | Sana Biotechnology, Inc. | 941.68M | -0.32% | 2,038,952 | - |
| 387 | GERN | Geron Corporation | 923.79M | - | 5,209,660 | 196.12M |
| 388 | ANNX | Annexon, Inc. | 912.60M | -3.97% | 2,216,343 | - |
| 389 | PHAR | Pharming Group N.V. | 911.72M | -2.67% | 10,008 | 369.49M |
| 390 | GLAS | Glass House Brands Inc. | 911.16M | -0.74% | 144,553 | 177.68M |
| 391 | OPK | OPKO Health, Inc. | 906.11M | 0.84% | 2,734,391 | 581.12M |
| 392 | LBRX | LB Pharmaceuticals Inc | 886.11M | -1.62% | 190,200 | - |
| 393 | INMD | InMode Ltd. | 882.90M | -0.71% | 444,796 | 374.64M |
| 394 | REPL | Replimune Group, Inc. | 882.26M | 2.74% | 4,474,429 | - |
| 395 | TALK | Talkspace, Inc. | 872.74M | - | 993,395 | 238.37M |
| 396 | TBPH | Theravance Biopharma, Inc. | 871.23M | -0.71% | 939,806 | 109.78M |
| 397 | ABUS | Arbutus Biopharma Corporation | 871.14M | -3.29% | 1,818,009 | 191.45M |
| 398 | AMPH | Amphastar Pharmaceuticals, Inc. | 865.54M | -0.61% | 437,415 | 720.53M |
| 399 | PHAT | Phathom Pharmaceuticals, Inc. | 845.93M | -2.65% | 620,355 | 204.89M |
| 400 | ODTX | Odyssey Therapeutics, Inc. | 841.70M | -0.17% | 224,539 | 1.06M |
| 401 | DBVT | DBV Technologies S.A. | 839.30M | -0.88% | 423,183 | 5.04M |
| 402 | SLDB | Solid Biosciences Inc. | 831.90M | -3.10% | 1,000,538 | - |
| 403 | HSTM | HealthStream, Inc. | 827.67M | -0.53% | 108,516 | 311.78M |
| 404 | TENX | Tenax Therapeutics, Inc. | 801.12M | -1.07% | 822,996 | - |
| 405 | AVR | Anteris Technologies Global Corp. | 801.08M | -2.72% | 717,449 | 1.85M |
| 406 | BBNX | Beta Bionics, Inc. | 794.09M | 3.07% | 711,602 | 110.24M |
| 407 | ACRS | Aclaris Therapeutics, Inc. | 777.93M | -1.94% | 867,365 | 8.37M |
| 408 | CTMX | CytomX Therapeutics, Inc. | 766.31M | -2.76% | 5,536,415 | 35.54M |
| 409 | SIBN | SI-BONE, Inc. | 759.26M | -1.50% | 371,801 | 206.22M |
| 410 | DRUG | Bright Minds Biosciences Inc. | 755.06M | -1.98% | 212,179 | - |
| 411 | AURA | Aura Biosciences, Inc. | 752.24M | -2.43% | 420,697 | - |
| 412 | SSII | SS Innovations International, Inc. | 750.49M | 3.02% | 52,910 | 48.47M |
| 413 | NGNE | Neurogene Inc. | 744.07M | 0.08% | 158,934 | 925.00K |
| 414 | DSGN | Design Therapeutics, Inc. | 741.36M | -5.57% | 433,762 | - |
| 415 | RIGL | Rigel Pharmaceuticals, Inc. | 733.98M | -2.15% | 416,142 | 299.77M |
| 416 | FTH | Faeth Therapeutics, Inc. | 726.70M | 8.97% | 122,795 | - |
| 417 | CSTL | Castle Biosciences, Inc. | 724.73M | -1.10% | 265,036 | 339.92M |
| 418 | EVO | Evotec SE | 721.14M | 1.02% | 82,193 | 859.03M |
| 419 | ZVRA | Zevra Therapeutics, Inc. | 711.15M | -5.79% | 1,139,228 | 122.29M |
| 420 | MNPR | Monopar Therapeutics Inc. | 709.40M | -4.70% | 121,668 | - |
| 421 | OCS | Oculis Holding AG | 708.35M | -3.77% | 258,775 | 1.40M |
| 422 | CADL | Candel Therapeutics, Inc. | 701.20M | -5.99% | 1,115,404 | - |
| 423 | CLYM | Climb Bio, Inc. | 699.72M | -3.78% | 845,913 | - |
| 424 | CBLL | CeriBell, Inc. | 699.28M | -1.55% | 231,407 | 95.07M |
| 425 | OMER | Omeros Corporation | 696.97M | -0.62% | 1,046,595 | 9.89M |
| 426 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 674.50M | -1.64% | 203,976 | - |
| 427 | SGP | SpyGlass Pharma, Inc. | 669.34M | 1.26% | 101,660 | - |
| 428 | EVH | Evolent Health, Inc. | 667.01M | 2.07% | 1,330,834 | 1.89B |
| 429 | BWAY | BrainsWay Ltd. | 666.48M | 4.90% | 323,774 | 56.22M |
| 430 | PHR | Phreesia, Inc. | 660.15M | -0.28% | 499,660 | 495.59M |
| 431 | GYRE | Gyre Therapeutics, Inc. | 655.55M | -2.81% | 52,766 | 117.05M |
| 432 | MDXG | MiMedx Group, Inc. | 644.94M | 0.70% | 737,038 | 389.42M |
| 433 | ACHV | Achieve Life Sciences, Inc. | 640.59M | -0.48% | 915,470 | - |
| 434 | TCMD | Tactile Systems Technology, Inc. | 640.37M | -1.22% | 185,606 | 343.52M |
| 435 | SPRY | ARS Pharmaceuticals, Inc. | 639.51M | -8.00% | 2,933,439 | 98.99M |
| 436 | SLBT | SL Science Holding Limited | 635.19M | -8.60% | 58,087 | - |
| 437 | IRWD | Ironwood Pharmaceuticals, Inc. | 633.76M | -0.26% | 1,801,180 | 361.51M |
| 438 | CERS | Cerus Corporation | 631.16M | 0.64% | 1,921,467 | 216.56M |
| 439 | IMMX | Immix Biopharma, Inc. | 626.47M | -14.15% | 3,919,461 | - |
| 440 | ALLO | Allogene Therapeutics, Inc. | 610.92M | -1.12% | 3,466,389 | 22.00K |
| 441 | CRMD | CorMedix Inc. | 610.36M | -7.60% | 1,156,243 | 400.05M |
| 442 | TECX | Tectonic Therapeutic, Inc. | 605.13M | -1.63% | 145,582 | - |
| 443 | CTKB | Cytek Biosciences, Inc. | 591.47M | -0.87% | 768,030 | 204.17M |
| 444 | AGMB | AgomAb Therapeutics NV | 589.99M | -0.50% | 42,680 | - |
| 445 | FDMT | 4D Molecular Therapeutics, Inc. | 579.74M | 0.91% | 821,432 | 88.24M |
| 446 | WEAV | Weave Communications, Inc. | 568.89M | -1.11% | 1,191,793 | 248.72M |
| 447 | NVCT | Nuvectis Pharma, Inc. | 568.41M | -5.80% | 339,708 | - |
| 448 | ANGO | AngioDynamics, Inc. | 566.67M | 1.48% | 500,502 | 320.17M |
| 449 | MYGN | Myriad Genetics, Inc. | 559.13M | -4.21% | 687,176 | 829.00M |
| 450 | FLGT | Fulgent Genetics, Inc. | 556.94M | -2.73% | 218,494 | 320.35M |
| 451 | PRME | Prime Medicine, Inc. | 550.88M | -2.56% | 3,290,218 | 4.03M |
| 452 | TOI | The Oncology Institute, Inc. | 549.91M | 2.80% | 1,012,992 | 545.76M |
| 453 | ALT | Altimmune, Inc. | 546.47M | -2.09% | 2,614,486 | 36.00K |
| 454 | NPCE | NeuroPace, Inc. | 536.98M | -2.05% | 62,563 | 99.53M |
| 455 | RGNX | REGENXBIO Inc. | 533.53M | 4.35% | 2,280,553 | 87.82M |
| 456 | SOPH | SOPHiA GENETICS SA | 531.06M | 7.84% | 628,147 | 81.18M |
| 457 | RLMD | Relmada Therapeutics, Inc. | 524.45M | -4.58% | 2,528,563 | - |
| 458 | STTK | Shattuck Labs, Inc. | 522.96M | -9.43% | 1,744,189 | 1.00M |
| 459 | EIKN | Eikon Therapeutics, Inc. | 522.44M | -1.23% | 159,647 | - |
| 460 | ARVN | Arvinas, Inc. | 517.46M | 0.12% | 555,530 | 89.40M |
| 461 | CTEV | Claritev Corporation | 513.48M | -0.89% | 244,966 | 978.76M |
| 462 | CTNM | Contineum Therapeutics, Inc. | 505.84M | -4.92% | 189,950 | - |
| 463 | VSTM | Verastem, Inc. | 505.27M | -4.64% | 2,532,631 | 49.59M |
| 464 | TLRY | Tilray Brands, Inc. | 504.57M | -1.63% | 2,991,264 | 858.28M |
| 465 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 466 | KIDS | OrthoPediatrics Corp. | 501.37M | 1.56% | 177,331 | 243.30M |
| 467 | CBIO | Crescent Biopharma, Inc. | 500.10M | 2.03% | 218,090 | 11.88M |
| 468 | ZURA | Zura Bio Limited | 499.69M | -3.49% | 798,271 | - |
| 469 | ASMB | Assembly Biosciences, Inc. | 496.62M | -6.53% | 112,884 | 71.10M |
| 470 | SLN | Silence Therapeutics plc | 495.48M | -0.10% | 360,152 | 839.00K |
| 471 | AQST | Aquestive Therapeutics, Inc. | 494.97M | -4.25% | 1,434,323 | 50.27M |
| 472 | DNA | Ginkgo Bioworks Holdings, Inc. | 493.20M | -4.55% | 877,915 | 151.40M |
| 473 | NRC | NRC Health | 482.51M | -1.70% | 62,607 | 138.64M |
| 474 | ANL | Adlai Nortye Ltd. | 479.20M | 3.90% | 392,486 | 5.00M |
| 475 | PROK | ProKidney Corp. | 471.21M | -3.70% | 1,375,409 | 889.00K |
| 476 | OFIX | Orthofix Medical Inc. | 467.27M | -0.17% | 463,946 | 825.37M |
| 477 | RZLT | Rezolute, Inc. | 464.88M | -3.47% | 1,276,116 | - |
| 478 | VALN | Valneva SE | 460.86M | -3.20% | 25,427 | 180.25M |
| 479 | VMD | Viemed Healthcare, Inc. | 458.89M | -1.48% | 250,847 | 286.57M |
| 480 | PRTA | Prothena Corporation plc | 453.90M | 0.12% | 549,606 | 57.94M |
| 481 | CLPT | ClearPoint Neuro, Inc. | 451.34M | -0.66% | 572,984 | 40.61M |
| 482 | OCGN | Ocugen, Inc. | 450.23M | -2.21% | 4,634,363 | 4.47M |
| 483 | CABA | Cabaletta Bio, Inc. | 448.40M | -2.83% | 2,691,872 | - |
| 484 | VREX | Varex Imaging Corporation | 447.60M | 0.66% | 260,411 | 857.50M |
| 485 | ARTV | Artiva Biotherapeutics, Inc. | 444.58M | -6.25% | 195,870 | 251.00K |
| 486 | SGMT | Sagimet Biosciences Inc. | 442.14M | -8.44% | 943,024 | - |
| 487 | EDIT | Editas Medicine, Inc. | 441.97M | -3.36% | 1,402,409 | 38.69M |
| 488 | HELP | Cybin Inc. | 440.71M | -1.93% | 1,295,267 | - |
| 489 | KYTX | Kyverna Therapeutics, Inc. | 440.16M | -2.82% | 1,434,320 | - |
| 490 | SRTA | Strata Critical Medical, Inc. | 437.82M | -1.75% | 1,075,793 | 228.58M |
| 491 | SI | Shoulder Innovations, Inc. | 435.30M | -2.78% | 57,834 | 53.89M |
| 492 | DCTH | Delcath Systems, Inc. | 434.63M | -1.72% | 329,822 | 90.44M |
| 493 | OVID | Ovid Therapeutics Inc. | 430.21M | -5.53% | 1,283,646 | 7.12M |
| 494 | CCRN | Cross Country Healthcare, Inc. | 428.22M | 0.11% | 2,326,959 | 1.00B |
| 495 | CYH | Community Health Systems, Inc. | 422.61M | -5.45% | 3,118,503 | 12.29B |
| 496 | PBYI | Puma Biotechnology, Inc. | 422.47M | -2.70% | 461,634 | 227.18M |
| 497 | PACB | Pacific Biosciences of California, Inc. | 422.42M | -5.56% | 10,874,078 | 160.03M |
| 498 | NNNN | Anbio Biotechnology | 417.84M | 0.32% | 22,207 | 8.65M |
| 499 | EVMN | Evommune, Inc. | 415.29M | -5.02% | 709,479 | 10.00M |
| 500 | KMDA | Kamada Ltd. | 414.14M | 0.57% | 50,074 | 181.68M |